Columbia University and Pfizer to Establish Clinical Trials Diversity Initiative

Columbia pfizer clinical trial 16

Columbia University Irving Medical Center, its Herbert Irving Comprehensive Cancer Center, and Pfizer Inc. are joining forces to increase the participation of underrepresented minorities in clinical trials and enhance the diversity of clinical researchers.

Improving diversity among clinical trial participants is a critical step toward reducing racial and ethnic disparities in health.